Products
-
Archive: ICH GCP E6(R3) Updates: Sponsor Quality Management - Risk-Based/Risk Management Requirements and Approaches for Compliance -
Archive: Implementation of Procedural Documents -
Archive: Implementing Quality Agreements -
Archive: Improving Readability of SOPs and Other Procedural Documents -
Archive: Informed Consent Content & Process Requirements -
Archive: Informed Consent Procedure: Lessons Learned from Inspection Findings -
Archive: Inspection Readiness: Understanding BIMO Inspection Requirements for Sponsors, CROs, Monitors and Investigators -
Archive: Introduction to Clinical Research -
Archive: Introduction to Data Management -
Archive: Introduction to Medicare Coverage Analysis: Impact on Site Revenue Cycles -
Archive: Introduction to Statistics for Non-Statisticians -
Archive: Introduction to the FDA -
Archive: Investigational Product Accountability Best Practices -
Archive: Investigator Initiated Trials: Roles and Responsibilities -
Archive: Investigator Selection Criteria & Strategies -
Archive: Key Considerations in Medical Writing: The Clinical Study Protocol, Investigator's Brochure, Informed Consent Form, and Adverse Events Narratives -
Archive: Leading Teams in a Changing Clinical Research Environment -
Archive: Making Good Teams Better: Taking Your Cross-Functional Global Team -
Archive: Managing Clinical Trials During the COVID-19 Pandemic -
Archive: Managing CRAs to Improve Performance and Study Outcomes -
Archive: Managing Observational Studies -
Archive: Managing Phase I Clinical Trials -
Archive: Managing Risks in Outsourced Clinical Trials: Practical Approaches and Tools -
Archive: Medical Device Tracking
